Twitter
LinkedIn
Facebook
Instagram
Youtube
CONTACT
SPEAK TO A SCIENTIST
Services
Our Capabilities
Assay Focus
Biomarkers
Immunogenicity
Anti-drug Antibody (ADA) Assays
Neutralizing Antibody (NAb) Assays
Pharmacokinetics (PK)
Cell-Based Assays
Toxicology Studies
BioAgilytix Diagnostics
Biomarker Menu
Disease State Expertise
Oncology
Metabolic
Autoimmune
Neurology
Industries Served
Pharma & Biotech
Agricultural Biotechnology
Our Quality Commitment
Management Processes
Project Management
Sample Management
Data Management
Solutions
Gene Therapy
Modified & Novel Vehicles for Gene Therapies
CAR T-Cell Therapy
Vaccines
Biosimilars
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Technology
Our Platforms
ELISA
MSD-ECL
Flow Cytometry
Quantitative Real-Time PCR (qPCR)
Roche cobas Analyzer
Gyrolab
Ella
LI-COR Odyssey
Luminex
Biacore
ImmunoCAP
ELISpot
Automation
Team
Leadership Team
Experts
Company
About Us
The BioAgilytix Way
US Headquarters
European Headquarters
French Research Tax Credit (CIR) Accreditation
Boston Laboratory
Mission, Vision & Values
Meet Our Partners
Awards
Resources
Resource Center
Gene & Cell Therapy Center
Our Blog
Case Studies
Testimonials
Molecular Moments
FAQ
Glossary
News
BioAgilytix in the News
Press Kit
Events
Careers
Careers at BioAgilytix
Analytical Assays Determine Biosimilar Product Quality
Read More
Immunogenicity Assessment of Gene Therapy Compounds
Read More
Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Read More
Clinical relevance of immunogenicity: an interview with Arno Kromminga
Read More
Exploratory biomarker testing: to qualify or validate the assay?
Read More
Immunogenicity Considerations for ADCs: A Focus on Neutralizing Antibody Assays
Read More
Bioanalysis Zone’s “Ask the Experts” Series on Biosimilars
Read More
Defining Best Practices for Biosimilar Development
Read More
Cell-Based Assays Keep Biosimilars on Track
Read More
Interview with Afshin Safavi (Founder & CSO, BioAgilytix) on biomarker analysis in support of preclinical and clinical studies
Read More
Meeting the Rigorous Demands of Biosimilar Pharmacokinetics
Read More
How to win client trust as a CRO
Read More
Running a successful CRO
Read More
How to set up a successful CRO by surrounding yourself with the right team members
Read More
Starting a CRO on Personal Credit
Read More
Parallelism and Matrix Interference: The Importance of Nomenclature (Part 1)
Read More
Growing Clinical Biomarker Assays
Read More
Development and validation of an alpha fetoprotein immunoassay
Read More
Implementation of a universal analytical method in early-stage development of human antibody therapeutics
Read More
Validation of a Gyrolab™ assay for quantification of rituximab in human serum
Read More
Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis
Read More